You are viewing the site in preview mode

Skip to main content

Table 2 Association between total M1 and M2 macrophages and clinicopathological characteristics

From: Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer

Characteristic M1 macrophages P M2 macrophages P
Gender:
 Female 99.5 (54–147) NS 101.5 (53–136) NS
 Male 96 (61–147) 117 (45–186)
Age, years:
  < 65 101 (61–147) NS 117 (45–145) NS
  ≥ 65 96 (54–147) 112 (53–186)
Smoking status:
 Smokers 98.5 (61–147) < 0.05* 117 (45–186) < 0.05*
 Non-smokers 87.5 (54–147) 101.5 (53–122)
Histological NSCLC type:
 Adenocarcinoma 94.5 (54–147) NS 111 (53–144) NS
 Squamous cell carcinoma 98 (62–136) 118 (45–186)
 Other 94 (61–147) 117 (87–121)
Stage:
 IA-IB 95 (62–128) NS 119 (64–186) NS
 IIA-IIB 95.5 (54–136) 112 (68–150)
 IIIA-IIIB 104 (61–147) 117 (45–145)
pT status:
 pT1a-2b 96 (54–147) NS 115 (64–186) NS
 pT3–4 97.5 (61–147) 117 (45–137)
Lymph node status:
 Negative (N0) 95 (54–133) NS 116 (64–186) NS
 Positive (N1-N3) 99 (61–147) 115 (45–150)
Differentiation:
 Poor 97 (54–133) NS 118 (53–186) < 0.05*
 Well-moderate 95 (61–147)   108 (45–137)  
COPD:
 Present 103 (73–147) NS 116 (74–186) NS
 Absent 94.5 (54–147)   115 (45–145)
  1. The number of macrophages represents median (range) per ten high-power fields in tumor tissue (the sum of macrophages in tumor islets and stroma)
  2. NS not significant
  3. *P < 0.05, Mann-Whitney test